Abstract: The present invention relates to a combination formulation containing metformin for treating non-insulin-dependent diabetes and an HMG-CoA reductase inhibitor for treating dyslipidemia. The present invention provides a combination formulation and a method for preparing the combination formulation, wherein the combination formulation contains metformin and an HMG-CoA reductase inhibitor, and has effectively improved stability by blocking physical and chemical reactions between the active ingredients while securing the stable release of respective active ingredients.

Abstract: The present invention provides a method for preparing a compound with a benzimidazole structure with an excellent yield using a low-cost starting material, not requiring an additional separation process, or not using a dangerous reagent during the manufacturing process. Furthermore, the present invention also provides an intermediate and a final product produced by the preparing method.

Abstract: A medical dressing is used to dress and treat skin wounds such as burns, cuts or traumatic injuries, and a method for making the same. The medical dressing includes an auxiliary release paper which makes it convenient to separate a pressure sensitive adhesive sheet from a release paper and is very easily separated from the pressure sensitive adhesive sheet after application to a wound site, thus improving the convenience of use of the dressing, and prevents the contamination of the pressure sensitive adhesive sheet in the process of either separating the pressure sensitive adhesive sheet from the release paper or separating the auxiliary release paper, thus preventing the secondary bacterial infection of a wound site, and is not exposed to the outside so that the dressing has an improved appearance and is convenient to carry and store.

Abstract: Provided are a semiconductor device and a method for fabricating the same. The semiconductor device includes an active fin protruding upwardly from a substrate and extending in a first direction and a gate structure extending in a second direction intersecting to cross the active fin, where a first width of a lower portion of the gate structure that contacts the active fin is greater than a second width of the lower portion of the gate structure that is spaced apart from the active fin.

Abstract: A semiconductor device and a method of manufacturing a semiconductor device, the device including an active fin protruding from a substrate and extending in a first direction, a first device isolation region disposed at a sidewall of the active fin and extending in a second direction, the second direction crossing the first direction, a normal gate electrode crossing the active fin, a first dummy gate electrode having an undercut portion on the first device isolation region, the first dummy gate electrode extending in the second direction, and a first filler filling the undercut portion on the first device isolation region, wherein the undercut portion is disposed at a lower portion of the first dummy gate electrode.

Abstract: The present invention provides a method for preparing a compound with a benzimidazole structure with an excellent yield using a low-cost starting material, not requiring an additional separation process, or not using a dangerous reagent during the manufacturing process. Furthermore, the present invention also provides an intermediate and a final product produced by the preparing method.

Abstract: The present invention relates to a stabilized pemetrexed formulation, and more specifically, to a stabilized pemetrexed formulation comprising acetylcysteine as an antioxidant and sodium citrate as a buffering agent. Additionally, the present invention relates to a pemetrexed formulation filled in a sealed container, comprising pemetrexed or a pharmaceutically acceptable salt thereof as an active ingredient, wherein the oxygen gas content within the headspace of the container is 3 v/v % or less.

Abstract: The present invention relates to a stabilized pemetrexed formulation, and more particularly to a stabilized pemetrexed formulation comprising acetylcysteine as antioxidant and a citrate salt as buffer.

Abstract: A structure of an exterior door strip includes a mounting portion mounted to an outer side of a outer door panel positioned, and a SUS trim coupled to an outer side of the mounting portion, and including: a first mounting portion formed in a longitudinal direction and having an end piece; a bridge connected to an other end of the first mounting portion; and a second mounting portion connected to the other end of the bridge and having a screw hole, in which the first mounting portion, the bridge, and the second mounting portion are integrally formed, and torque caused by screw engagement of the second mounting portion is not transmitted to the first mounting portion, thereby resolving a problem regarding quality in external appearance of the vehicle, preventing corrosion caused by rain water, and reducing production costs of the vehicle.

Abstract: The present invention relates to a stabilized pemetrexed formulation, and more particularly to a stabilized pemetrexed formulation comprising acetylcysteine as antioxidant and a citrate salt as buffer.

Abstract: A method of computing a peak current density specification (jpeakspec) for an electrical conductor line of an integrated circuit (IC) resulting from conducting pulsed electrical current represented as a current waveform. An on-time (ton) is identified for the current waveform based on a current density being greater than or equal to (?) a predetermined current density level. The jpeakspec is computed for the electrical conductor line using a jpeakspec modeling equation which includes the ton for the current waveform and a thermal time constant (?) for the electrical conductor line.

Abstract: Provided are a time synchronization apparatus and method for a network camera and a network video recorder (NVR) connected to the network camera. The apparatus includes: a data receiving unit receiving a data stream from the network camera, the data stream including timestamp information of the network camera; a noise determining unit determining whether time information input from the network camera is a noise based on a timestamp of the network camera contained in the timestamp information; and a setting control unit setting a timestamp of the NVR based on the determining of the noise determining unit, wherein the data stream comprises data obtained by the network camera and the timestamp information of the network camera which indicates a time when the data stream was transmitted from the network camera.

Abstract: A method of controlling a CVVT may include a) checking whether a predetermined time has passed, after engine starts. b) locking an actuator by driving oil control valve with different driving currents in accordance with whether a predetermined time has passed after the engine starts. c) unlocking the actuator or feed-backing control cam phase in accordance with whether the actuator is unlocked. d) feed-backing control cam phase or locking the actuator by driving oil control valve with predetermined current in accordance with whether control cam phase is not reached before the actuator is locked. e) driving the oil control valve with predetermined current to maintain the control cam phase or turning off the oil control valve, after feed-backing control cam phase or locking the actuator by driving the oil control valve with predetermined current in accordance with whether the control cam phase is not reached before the actuator is locked.

Abstract: A resistor is formed on field oxide with a portion of the resistor body configured to overlap an active region in an integrated circuit (IC) substrate to provide heatsinking for the resistor body. In one embodiment, cooling fingers extend from the resistor body beyond the field oxide to overlap the active region. In another embodiment, minor areas of the resistor body overlap the active region. The resistor body may be formed of polycrystalline silicon (polysilicon), silicided polysilicon, or metal. An oxide having greater thermal conductance than the field oxide is formed between the overlapping parts of the resistor body and the active region.

Abstract: The present invention relates to a long-acting human growth hormone NexP-hGH protein and its production method. More specifically, it relates to a specific isoform of long-acting human growth hormone NexP-hGH protein in which human growth hormone is fused with a highly glycosylated alpha-1 antitrypsin mutant whereby long-acting properties in vivo are increased.

Abstract: A structure of an exterior door strip includes a mounting portion mounted to an outer side of a outer door panel positioned, and a SUS trim coupled to an outer side of the mounting portion, and including: a first mounting portion formed in a longitudinal direction and having an end piece; a bridge connected to an other end of the first mounting portion; and a second mounting portion connected to the other end of the bridge and having a screw hole, in which the first mounting portion, the bridge, and the second mounting portion are integrally formed, and torque caused by screw engagement of the second mounting portion is not transmitted to the first mounting portion, thereby resolving a problem regarding quality in external appearance of the vehicle, preventing corrosion caused by rain water, and reducing production costs of the vehicle.

Abstract: A surveillance server connected to a camera through a network is provided, the camera acquiring an image of a surveillance area. The surveillance server includes: a data acquisition unit configured to acquire from the camera image data of the image that is encrypted; a mode selection unit configured to select a processing mode of the image data; and a decryption control unit configured to decrypt the image data in response to selection of a first mode.

Abstract: A method of controlling a CVVT may include a) checking whether a predetermined time has passed, after engine starts. b) locking an actuator by driving oil control valve with different driving currents in accordance with whether a predetermined time has passed after the engine starts. c) unlocking the actuator or feed-backing control cam phase in accordance with whether the actuator is unlocked. d) feed-backing control cam phase or locking the actuator by driving oil control valve with predetermined current in accordance with whether control cam phase is not reached before the actuator is locked. e) driving the oil control valve with predetermined current to maintain the control cam phase or turning off the oil control valve, after feed-backing control cam phase or locking the actuator by driving the oil control valve with predetermined current in accordance with whether the control cam phase is not reached before the actuator is locked.

Abstract: The present invention relates to a continuous process for preparing microspheres and microspheres prepared thereby, and in particular, a process for preparing microspheres comprising steps of injecting a first emulsion and a second emulsion at the same time to form microspheres instantaneously, applying high pressure to the microspheres formed, and injecting the microspheres into an agitator, wherein the steps can be carried out continuously, and microspheres prepared thereby. When microspheres are prepared using the method of the present invention, scale variables, which have been the biggest disadvantage in existing preparation methods of microspheres, can be significantly reduced, drug encapsulation efficiency can be improved, and small and uniform particles can be obtained.

Abstract: The present invention relates to a method of preparing microspheres by using a polymer having a sol-gel transition property and microspheres prepared thereby, and more particularly, to a method of preparing microspheres by using a polymer having a sol-gel transition property and microspheres prepared thereby capable of preventing a solvent in a polymer solution for a carrier from being rapidly diffused to the aqueous medium before formation of the microspheres to reduce porosity of the microspheres and reduce surface roughness of the microspheres in order to obtain microspheres having a sphere shape, and increasing an encapsulation ratio of a bioactive substance, by using a polymer having a sol-gel transition property as a surfactant included in an aqueous medium into which a primary emulsion is injected and gelating a secondary emulsion formed after injecting the primary emulsion using the sol-gel transition property of the polymer used as the surfactant.